NAFDAC  Don Approve Chloroquine For Clinical Trial Against Coronavirus

As everybody dey search for cure for COVID-19, The National Agency for Food and Drug Administration and Control ( NAFDAC ) don approve the production of chloroquine for clinical trials.
Mojisola Adeyeye, wey bi the Director-General of the agency, yarn dis tori  on Friday.
Make Una read wetin im yarn
NAFDAC is not approving Chloroquine as a product that has can be used for Coronavirus because there is no submission to us for registration but because it is under clinical trials, NAFDAC approves medicines meant for clinical trials.
Therefore the medicine is being approved just for the clinical trials,”
“Right now, we have asked one company to make a batch of Chloroquine for the purpose of the clinical trial,” 

Leave a Reply